Sign in

George Seed

@seedgeorge.bsky.social
110 followers 32 following 9 posts

Cancer genomics at the ICR London, translating data into outcomes for patients.

PostsRepliesMedia
Reposted by George Seed
Trevor Graham @trevorgraham.bsky.social · 07/10/2025
Great flash talks from Anton Patrikeev (HPV evolution in head and neck cancer) and Florian Gabel (resistance evolution in prostate cancer) both from our @cec-icr.bsky.social @icr.ac.uk #CrickCancerConf
091
Reposted by George Seed
Eli Van Allen @vanallenlab.bsky.social · 15/04/2025
In this perspective, we examined the present and future interface of AI & translational cancer research for @cp-cancercell.bsky.social - led by the stellar Dr. Josephine Yates! @danafarber.bsky.social @broadinstitute.org www.sciencedirect.com/science/arti...
sciencedirect.com
New horizons at the interface of artificial intelligence and translational cancer research
Artificial intelligence (AI) is increasingly being utilized in cancer research as a computational strategy for analyzing multiomics datasets. Advances…
062
Reposted by George Seed
Eli Van Allen @vanallenlab.bsky.social · 10/02/2025
Here's our latest - jointly with @rhaq1.bsky.social lab & co-lead by Drs. Schiantarelli, Benamar, Park et al - studying why some tumors stop responding to immunotherapy. This continues to be a tough puzzle to solve, but important for science & patients alike...
1184
Reposted by George Seed
Prince Charles Cinema @princecharlescinema.com · 28/01/2025
#SaveThePCC Some of you may have read about the situation regarding our new landlord wishing to add a new redevelopment break clause, with only 6 months notice to our lease. For now, we're simply asking you all to share & sign the petition below; you.38degrees.org.uk/p/princechar...
you.38degrees.org.uk
Save The Prince Charles Cinema
The iconic Prince Charles Cinema in London’s West End future is under serious threat! We are beyond disappointed that our landlords Zedwell LSQ Ltd and their ultimate parent company Criterion Capital...
8121502079
George Seed @seedgeorge.bsky.social · 12/12/2024
Salary? Good, I bet?
000
George Seed @seedgeorge.bsky.social · 12/12/2024
It's a great book, such nice production quality.
000
Reposted by George Seed
Ellie Davison @drelliedavison.bsky.social · 09/12/2024
PARP inhibitor, olaparib, has transformed treatment for men whose #prostatecancer has DNA repair defects, but most cancers eventually become resistant. @seedgeorge.bsky.social at @icrlondon.bsky.social has uncovered genomic changes that predict how long men will respond.🧵 doi.org/10.1016/j.cc...
151
George Seed @seedgeorge.bsky.social · 05/12/2024
This work was supported in part by @prostatecanceruk.bsky.social, who really are leaders in supporting research and have been fantastic to work with.
350
George Seed @seedgeorge.bsky.social · 05/12/2024
Delighted that a major project of my post-doctoral fellowship in the de Bono lab has been published. A really interesting story, featuring the likes of @icrlordlab.bsky.social @boragurel.bsky.social among many others at @icrlondon.bsky.social and elsewhere.
1125
Reposted by George Seed
Hayley Luxton (She/They) @drluxton.bsky.social · 28/11/2024
This weeks coffee club paper focuses on genomic changes linked to PARP inhibitor resistance ☕ The work was led by @prostatecanceruk.bsky.social's Travel Prize Fellow @seedgeorge.bsky.social from @icrlondon.bsky.social Congratulations to George and team 🥳 t.co/rC22HnAKIs #prostatecancer #research
1123
George Seed @seedgeorge.bsky.social · 28/11/2024
What a steal!
020
George Seed @seedgeorge.bsky.social · 22/11/2024
"Shock Christmas Message: Doctors say ABSENCE Makes the Heart Grow FONDER" Health experts today warn about the risks of over-fondness and wistfulness, as growing absence rates lead to a rise in diagnoses nationwide.
030
George Seed @seedgeorge.bsky.social · 20/11/2024
Don't forget to save these functions in different scripts that are all sourced at different points.
000
George Seed @seedgeorge.bsky.social · 20/11/2024
It's a challenge to strike this balance, partly because of the well-described pressures we are under to deliver "results". Your boss lets you know there will be some transcriptome data coming - how much of a deep dive can you afford to do on the methods? It's non-trivial.
010
George Seed @seedgeorge.bsky.social · 20/11/2024
I'd say that while frequently packages 'work' - ie. produce output without complaint - but is the output useful? Has it worked 'correctly'? It's part of the challenge of the field, really, and ties in with the thread: the user has to understand what the inputs and outputs look like. And that's hard!
000